middle.news
Why Did AVITA Medical’s Q2 Revenue Soar Yet Guidance Fall?
8:34am on Friday 8th of August, 2025 AEST
•
Healthcare
Read Story
Why Did AVITA Medical’s Q2 Revenue Soar Yet Guidance Fall?
8:34am on Friday 8th of August, 2025 AEST
Key Points
Q2 commercial revenue rises 21% to $18.4 million
Net loss improves to $9.9 million from $15.4 million year-on-year
Medicare Administrative Contractor payment delays reduce RECELL demand
Full-year 2025 revenue guidance cut to $76-$81 million from $100-$106 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avita Medical (ASX:AVH)
OPEN ARTICLE